Literature DB >> 11869499

Outcomes of implant prosthodontic treatment in older adults.

S Ross Bryant1, George A Zarb.   

Abstract

Older adults are expected to account for an increasingly disproportionate number of individuals needing oral implant prostheses. However, this biotechnology was initially studied for predominantly middle-aged edentulous patients, not elderly people. High rates of success and minimal crestal bone loss have been reported for oral implants mainly in this group. The results of studies at the University of Toronto now clearly support earlier reports that older adults respond to oral implants in the same manner as younger adults, despite their tendency for systemic illness, including osteoporosis. However, unfavourable jawbone quantity and quality, particularly atrophy of the maxilla, impaired implant success. Furthermore, placement of implants in sites that had been edentulous for shorter periods was associated with greater crestal bone loss, a finding that may have implications for younger adults undergoing such treatment. The major decision-making challenge in managing depleted dentitions and complete edentulism in an aging society now lies in differentiating the treatment outcomes, especially patient-mediated assessments (including economic analyses), of the various prosthodontic options available for older adults.

Entities:  

Mesh:

Year:  2002        PMID: 11869499

Source DB:  PubMed          Journal:  J Can Dent Assoc        ISSN: 0709-8936            Impact factor:   1.316


  3 in total

Review 1.  Significance of osteoporosis in craniomaxillofacial surgery: a review of the literature.

Authors:  B Hohlweg-Majert; R Schmelzeisen; B M Pfeiffer; E Schneider
Journal:  Osteoporos Int       Date:  2005-07-16       Impact factor: 4.507

2.  Repeatedly Applied Peptide Film Kills Bacteria on Dental Implants.

Authors:  Cate Wisdom; Casey Chen; Esra Yuca; Yan Zhou; Candan Tamerler; Malcolm L Snead
Journal:  JOM (1989)       Date:  2019-01-18       Impact factor: 2.471

3.  Bone marrow stromal cells from low-turnover osteoporotic mouse model are less sensitive to the osteogenic effects of fluvastatin.

Authors:  Yukari Oda; Hodaka Sasaki; Tadashi Miura; Takuya Takanashi; Yoshitaka Furuya; Masao Yoshinari; Yasutomo Yajima
Journal:  PLoS One       Date:  2018-08-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.